COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor

Official Title

COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor - CAASPtrial

Brief Summary

Capture of anxiety for anomalies, stillbirth and preterm Labor of pregnant women during COVID-19 pandemia

Status

Completed

Conditions

Anxiety State

Eligibility Criteria

Inclusion Criteria:

- consenting ability

Exclusion Criteria:

- language barrier

- uncompleted questionary

Eligibility Gender

Female

Eligibility Age

Minimum: 18 Years ~ Maximum: N/A

Countries

Germany

Locations

University Hospital of Halle
Halle, Saxony Anhalt, Germany

NCT Number

NCT04568551

MeSH Terms

Obstetric Labor, Premature

Stillbirth

Anxiety Disorders

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Martin-Luther-Universität Halle-Wittenberg

COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA